0001209191-22-049156.txt : 20220908
0001209191-22-049156.hdr.sgml : 20220908
20220908161911
ACCESSION NUMBER: 0001209191-22-049156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220906
FILED AS OF DATE: 20220908
DATE AS OF CHANGE: 20220908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pesquin Gustavo
CENTRAL INDEX KEY: 0001944691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 221234039
MAIL ADDRESS:
STREET 1: 4 PARK LANE
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-06
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001944691
Pesquin Gustavo
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
08807
0
1
0
0
See Remarks
Restricted Stock Units
2022-09-06
4
A
0
444444
0.00
A
Class A Common Stock
444444
444444
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
The restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.
Title: Executive Vice President, Chief Commercial Officer - Specialty
/s/ Jason B. Daly, Attorney-in-Fact
2022-09-08